Dawnrays Pharmaceutical (2348 HK)

Dawnrays Pharmaceutical Holdings Ltd. is a pharmaceutical group primarily engaged in the development, manufacturing, and sales of cephalosporin antibiotics and various system-specific generic medicines. Its product portfolio includes pharmaceutical intermediates, bulk medicines, and finished drugs for therapeutic areas such as cardiovascular, anti-HBV, and anti-allergic systems. The company was founded in December 1995 and has its main operations in Suzhou, Jiangsu Province, China, with a corporate presence in Hong Kong.